Perrigo Co PLC (PRGO): Operating Cash Flow
$238.50M
Year ended 2025-12-31
$196.10M
Trailing 12 months to 2026-06-27
-8.1%
3-year compound annual growth
-17.8%
5-year compound annual growth
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $238.50M | -34.3% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $362.90M | -10.5% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $405.50M | +32.0% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $307.30M | +96.6% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $156.30M | -75.4% | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | $636.20M | +64.1% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $387.80M | -34.6% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $593.00M | -15.2% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $698.90M | +6.7% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $654.90M | n/a | 2019-02-27, From 2016-01-01 |
| No annual figure between 2015-06-27 and 2016-12-31. | |||
| 2015-06-27 | $855.20M | +35.1% | 2018-03-01, From 2014-06-29 |
| 2014-06-28 | $633.00M | n/c | 2017-05-22, From 2013-06-30 |
| 2013-06-29 | $553.80M | +7.9% | 2015-08-13, From 2012-07-01 |
| 2012-06-30 | $513.40M | n/a | 2014-08-14, From 2011-06-26 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Perrigo Co PLC (PRGO) | 2025-12-31 | $238.50M | -34.3% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $1.36B | -2.9% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $560.00M | +3.5% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $524.08M | n/m |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $1.13B | n/m |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $827.99M | +44.5% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $1.56B | +17.6% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $339.99M | +15.2% |
| Organon & Co. (OGN) | 2025-12-31 | $700.00M | -25.5% |
Compare PRGO, JAZZ, ELAN, ALNY side by side · Screen every company in Pharmaceutical Preparations ↗